ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,515.00
-30.00 (-1.18%)
At close: Sep 3, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 67.78 billion as of September 4, 2026. Its market cap has increased by 95.00% in one year.
Market Cap
67.78B
Enterprise Value
65.99B
Revenue
12.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,515.00
ChartMarket Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 67.78B, an increase of 167.43%. That is a compound annual growth rate of 15.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 67.78B | 104.09% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 76.70B |
| SunBio,Inc. | 75.72B |
| CTCBIO | 74.48B |
| IMGT Co.,Ltd. | 71.33B |
| AriBioLab | 70.60B |
| Psomagen | 69.15B |
| Naturalendo Tech | 67.88B |
| PanGen Biotech | 67.37B |